Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool October 21, 2010 Moser & Hinmon	DRIP Candidate Winner: Becton, Dickinson In a health-care bloodbath, Becton, Dickinson pounds Walgreen to a pulp.
The Motley Fool July 27, 2007 Brian Orelli	Stability From a Likely Source Becton Dickinson's earnings are solid. The medical device and lab supply company has reported growth in earnings and increases in margins.
The Motley Fool April 27, 2005 Stephen D. Simpson	Becton, Dickinson's Boring Reliability This broadly diversified medical device company doesn't grow fast, but it is consistent. Investors looking for a stable and dependable company with broad exposure to the medical industry should take a look for themselves at Becton, Dickinson.
The Motley Fool October 7, 2010	DRIP Portfolio Candidate: Walgreen Why this nationally known drugstore should make it into your DRIP portfolio.
The Motley Fool October 13, 2010 Seth Jayson	From Gross to Net at Becton Dickinson With recent margins exceeding historical averages, medical device company Becton Dickinson looks like it's doing fine.
The Motley Fool September 24, 2008 Selena Maranjian	Beware of Rapidly Growing Dividends Look closely before you jump into some dividend-paying stocks. They're not always a good thing.
The Motley Fool July 23, 2010 Selena Maranjian	Reasonable Risks, Powerful Payoffs Riskier stocks can be worthwhile if you seek margins of safety.
The Motley Fool October 21, 2010 Anand Chokkavelu	6 Health-Care Stocks Near 52-Week Lows Here are the largest health care equipment and services companies (by market cap) that are hugging 52-week lows: Medtronic... Covidien... Stryker... Becton, Dickinson and Company... McKesson... Cardinal Health...
The Motley Fool August 18, 2009 Morgan Housel	Warren Buffett Goes Buying ... and Selling Warren Buffett's moves over the years would leave you well ahead of the pack. Here's a rundown of Berkshire's latest buys and sells.
The Motley Fool April 16, 2009 Selena Maranjian	Meet the Dividend Champions Some dividend-paying companies are more impressive than others. Take a look at: Emerson-Electric... Colgate-Palmolive... Lowe's... Kimberly-Clark... Becton Dickinson... McGraw-Hill... Family Dollar...
The Motley Fool July 19, 2010 Wenning & Hinmon	How We'll Build Our DRIP Portfolio How we'll select the portfolio components.
The Motley Fool July 15, 2010 Wenning & Hinmon	The Return of the DRIP Portfolio Building a portfolio a few hundred bucks at a time.
The Motley Fool October 28, 2010 Anand Chokkavelu	7 Health-Care Stocks Near 52-Week Highs Searching the market's peaks for possibilities.
The Motley Fool February 11, 2011 Rex Moore	Highest-Yielding Health Care Stocks (You Might Actually Want to Buy) How to combine high yield with low risk.
The Motley Fool May 19, 2010 April Taylor	Buffett Is Selling Warren Buffett reduced his stake in 13 holdings in the most recent quarter, with four being eliminated from the portfolio altogether.
The Motley Fool February 19, 2010 April Taylor	A Busy Oracle of Omaha Buffett's working on more than the railroad. Aside from Burlington Northern, Buffett sold more stocks than he bought.
The Motley Fool January 14, 2010 Jim Mueller	Roundtable: Which Health-Care Stocks to Buy Now Three Fool analysts give you their best ideas on where to put your money after the health-care reform bill makes it out of Congress.
The Motley Fool January 18, 2011 Russ Krull	Keep It or Sweep It: Johnson & Johnson? Should the company be held or sold?
The Motley Fool January 4, 2012	A Brief History of Becton, Dickinson's Returns While the past decade has seen valuations contract, the coming decade could see stable, even expanding, valuations.
The Motley Fool August 30, 2010 Todd Wenning	DRIP Portfolio Candidate: Chevron Why this energy titan makes a great DRIP investment.
The Motley Fool October 20, 2005 Stephen D. Simpson	Baxter Needs Growth Infusion This is a fine health-care company, but a sluggish top line suggests there are limits to how far it can go. Trading at nearly 20 times forward earnings, it seems like expectations of a growth revival are already in the stock.
The Motley Fool April 18, 2011 Andrew Tonner	Does Corning Deserve a Spot in Your Portfolio? A quick check of the numbers should help get us started.
The Motley Fool August 18, 2010 David Meier	Corning: Deflation Fighter Corning could be a good candidate to keep you ahead of the game.
The Motley Fool November 30, 2009 Rick Aristotle Munarriz	4 Dividend Stocks Showing You the Money Companies with growing yields can make you rich in more ways than the obvious: consider Roper, McCormick, Hormel, and Becton Dickinson.
The Motley Fool July 23, 2010 Jordan DiPietro	These 5 Stocks Won't Stop Paying You Cash "Dividend aristocrats" could help you get back in the retirement game.
Chemistry World October 7, 2014 Phillip Broadwith	Becton Dickinson to buy CareFusion for $12bn Medical devices giant Becton Dickinson has agreed to buy automation and infection prevention specialist CareFusion for over $12 billion.
The Motley Fool February 18, 2010 Morgan Housel	What the Smart Investors Are Buying Standing on the shoulders of giants. Blindly following the leaders is no substitute for learning from them.
BusinessWeek January 12, 2004 Gene G. Marcial	Quidel: Flu Test Fever With influenza on a rampage, shares of Quidel are grabbing the Street's attention.
The Motley Fool August 11, 2010 Charly Travers	Insiders Are Buying Quidel. Should You? Does insider buying and a cheap price make for a good buy?
The Motley Fool August 31, 2010 Jordan DiPietro	7 Health-Care Stocks Getting Slammed These dividend-paying health care stocks could be good bargains.
The Motley Fool March 18, 2009 Selena Maranjian	Better Than a Penny Stock Why take on big risks with penny stocks when you don't have to?
The Motley Fool September 28, 2010 Rich Smith	This Just In: Upgrades and Downgrades Intuitive Surgical in intensive care? Blame it on Goldman.
The Motley Fool August 27, 2010 Eben Esterhuizen	Warren Buffett's Trades: Visualizing the Oracle's Portfolio Tweaks A look at Berkshire Hathaway's recent moves.
The Motley Fool November 5, 2007 Brian Orelli	Can't Beat BD's Steady Growth Fourth-quarter results offer more of the same steady growth for medical technology company Becton, Dickinson.
The Motley Fool January 3, 2008 Brian Orelli	A Super Superbug Testing Market Becton, Dickinson gets FDA approval of its quick blood test for MRSA, the so-called superbug.
The Motley Fool March 13, 2009 Todd Wenning	7 Great American Stocks on Sale A good strategy in today's market is to invest slowly and methodically into undervalued companies without getting dragged down by commissions. A Dividend Reinvestment Plan, or DRIP, is a good way to do that. Take a look at seven.
The Motley Fool December 1, 2008 Rick Aristotle Munarriz	4 Stocks That Took a Hike These companies recently raised their dividends: Becton Dickson... McCormick... Landauer... York Water...
The Motley Fool November 3, 2005 Stephen D. Simpson	Becton, Dickinson: More Boring Growth This company may seem to be just a collection of boring businesses making things like syringes, reagents, and safety products. But shareholders aren't feeling too bored with today's strong stock performance.
The Motley Fool August 24, 2010 Dan Dzombak	The 15 Highest-Yielding Health-Care Equipment Stocks These fat yields may not be as promising as they seem.
The Motley Fool December 15, 2009 Jim Royal	What's Next on Warren Buffett's Buy List? It has been shown that investors who simply copied Warren Buffett's investments would have earned an average 24.6% annually for 30 years through 2006.
The Motley Fool April 20, 2007 Billy Fisher	Feverish Growth at Meridian Bioscience Looking to add a small-cap health-care stock to your portfolio? You might want to carefully consider the recent performance and future prospects of diagnostic-test-kit maker Meridian Bioscience.
The Motley Fool February 7, 2008 Brian Orelli	Invitrogen Integrates After a rough 2006 in which it struggled to integrate its acquisitions, Invitrogen used 2007 to show why it made all of its purchases.
The Motley Fool May 19, 2005 Tim Hanson	The Power of Free Money Hear that Drip? It's your portfolio growing. The best candidates for Drips (dividend reinvestment plans) are stocks that increase dividends regularly and appreciate in the market.
The Motley Fool November 27, 2006 Billy Fisher	Banner Year for Meridian Bioscience The little diagnostic-test-kit maker that could. The company has seen its stock price appreciate 27% over the past twelve months, and it recently reported a record fiscal 2006.
The Motley Fool January 26, 2006 Stephen D. Simpson	Little Bits Add Up at Becton Dickinson Nothing flashy here, but consistent performance has delivered exceptional value for this health care and medical technology company. This stock has been nearly a 46-bagger over the past 20 years.
The Motley Fool June 28, 2011 Jordan DiPietro	Should You Retire With Covidien? Covidien has a beta of 0.82, which is pretty low. Generally speaking, I like to see a beta below 1.2 for retirees, and Covidien fits the bill.